| dc.contributor.author | GALLAGHER, MICHAEL | en |
| dc.date.accessioned | 2017-07-20T13:58:20Z | |
| dc.date.available | 2017-07-20T13:58:20Z | |
| dc.date.issued | 2017 | en |
| dc.date.submitted | 2017 | en |
| dc.identifier.citation | MacDonagh L, Gallagher MF, Ffrench B, Gasch C et al, Targeting aldehyde dehygrogenase 1 (ALDH1) to circumvent cisplatin resistance in NSCLC, OncoTarget, 2017 | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.relation.ispartofseries | OncoTarget | en |
| dc.rights | Y | en |
| dc.title | Targeting aldehyde dehygrogenase 1 (ALDH1) to circumvent cisplatin resistance in NSCLC | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/gallagmi | en |
| dc.identifier.rssinternalid | 168457 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.subject.TCDTheme | Cancer | en |
| dc.subject.TCDTag | cancer stem cells | en |
| dc.identifier.orcid_id | 0000-0003-1636-2404 | en |
| dc.identifier.uri | http://hdl.handle.net/2262/80586 | |
